GV
Publicaties op Oncologisch.com
First-line pembrolizumab plus chemotherapy for gevorderd HER2-negative gastric or gastroesophageal junction adenocarc...
Neoadjuvant and Adjuvant Pembrolizumab in Locally Gevorderd Head and Neck Cancer.
Pembrolizumab plus chemotherapie versus placebo plus chemo bij HER2-negatief maagcarcinoom: KEYNOTE-859 fase III
Ipatasertib plus abiraterone bij mCRPC: IPATential150 fase III